Key facts
- Eximis Surgical’s last known valuation is $18.7M.
- It has raised $45.0M across 8 recorded rounds; the latest was Early Stage VC ($15.3M) in Mar 2023.
- Notable investors include MedTech Innovator, Springboard Enterprises, Innosphere Ventures, Daniel Weide, ForMED Ventures — 9 tracked in total.
- Eximis Surgical has filed 10 Form Ds with the SEC since 2015, most recently May 2024 ($15.3M sold to 12 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 8 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Eximis Surgical
Funding rounds
8 roundsAbout Eximis Surgical
Developer of a specimen removal device designed for laparoscopic surgery. The company's device integrates into physician protocols and reduces the time for laparoscopic specimen removal, reduces patient discomfort, delivers safe outcomes, separates the specimen into narrow stripes, and creates clean tissue segments for pathology identification, enabling surgeons to have minimally invasive surgery.
- Industry
- Surgical Devices
- Sector
- Healthcare
- HQ
- Louisville, CO, United States
- Founded
- 2014
- Employees
- 13
- Website
- eximissurgical.com/
- Ownership
- Privately Held (backing)
Eximis Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Eximis Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Eximis Surgical in its N-PORT filings yet. We sweep new filings monthly.